The situation of 12-year-old children using 0.01% atropine sulfate eye drops (EIKANCE) for 8 years

0.01% atropine sulfate eye drops (EIKANCE) is a low-concentration atropine preparation, mainly used to control the development of myopia in children, especially suitable for preschool and school-age children. In clinical practice, long-term use of low-concentration atropine is considered a relatively safe and effective intervention aimed at delaying axial growth and thereby reducing the risk of high myopia. For a 12-year-old child who has been using EIKANCE eye drops continuously for 8 years, it means that he has been receiving low-concentration atropine intervention since early school age. This situation is medically classified as long-term maintenance treatment.

The main purpose of long-term use of low-concentration atropine is to slow down the axial growth rate by reducing the excessive stimulation of the eyeball's accommodation response. Studies have shown that low concentrations of atropine do not significantly affect children's vision clarity or accommodative function, nor do they cause severe light sensitivity or mydriasis discomfort, making it a common drug choice for myopia management in school-age children. For a 12-year-old child, after 8 years of use, parents and doctors will pay attention to changes in vision, axial growth, and whether drug-related side effects occur. Clinically, regular follow-up is key, including visual acuity measurement, axial length monitoring and corneal health examination, to ensure the safety and effectiveness of long-term medication.

In long-term use,The advantage of EIKANCE eye drops is that low concentration can balance efficacy and safety. Compared with high-concentration atropine, which may cause pupil dilation, accommodation dysfunction and discomfort in close vision, a concentration of 0.01% is more easily tolerated by children and still has a certain myopia control effect. When parents observe their children's long-term use, they usually pay attention to whether their children have symptoms such as eye fatigue, photophobia, or difficulty seeing at close range in daily life. If these symptoms are mild or absent, the drug is well tolerated.

Reference materials:https://www.eikance.com.au/